Wildcat Capital Management, LLC Quant / Systematic

Location: New York, NY

CIK: 0001582384 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 14, 2024

Total Value: $276M (100.0% shares, 0.0% debt)

Holdings (16)

— FRONTIER COMMUNICATIONS PARE 12.5%
Value $34.38M Shares 1,412,617 Share Price $24.34 Est. Cost/Share $22.34 Unrealized @ Report Date —
GSHD GOOSEHEAD INS INC 12.5%
Value $34.38M Shares 516,008 Share Price $66.62 Est. Cost/Share $62.18 Unrealized @ Report Date +7.1%
MCO MOODYS CORP 11.7%
Value $32.31M Shares 82,208 Share Price $393.03 Est. Cost/Share $315.11 Unrealized @ Report Date +23.1%
MSFT MICROSOFT CORP 11.5%
Value $31.55M Shares 75,000 Share Price $420.72 Est. Cost/Share $276.41 Unrealized @ Report Date +50.3%
RLX RLX TECHNOLOGY INC 11.1%
Value $30.71M Shares 18,046,195 Share Price $1.70 * Est. Cost/Share $5.25 Unrealized @ Report Date -63.4%
GLBE GLOBAL E ONLINE LTD 10.6%
Value $29.13M Shares 801,477 Share Price $36.35 Est. Cost/Share $25.07 Unrealized @ Report Date +45.0%
DASH DOORDASH INC 8.7%
Value $24.1M Shares 243,683 Share Price $98.89 * Est. Cost/Share $81.41 Unrealized @ Report Date +69.2%
META META PLATFORMS INC 8.6%
Value $23.7M Shares 48,814 Share Price $485.58 Est. Cost/Share $171.20 Unrealized @ Report Date +182.0%
ALLO ALLOGENE THERAPEUTICS INC 2.9%
Value $7.878M Shares 1,920,787 Share Price $4.10 * Est. Cost/Share $24.98 Unrealized @ Report Date -82.1%
URGN UROGEN PHARMA LTD 2.7%
Value $7.434M Shares 495,606 Share Price $15.00 Est. Cost/Share $34.01 Unrealized @ Report Date -55.9%
— CONSOLIDATED COMM HLDGS INC 2.3%
Value $6.456M Shares 1,494,447 Share Price $4.32 Est. Cost/Share $6.02 Unrealized @ Report Date —
— SKILLZ INC 2.3%
Value $6.359M Shares 979,848 Share Price $6.49 Est. Cost/Share $19.79 Unrealized @ Report Date —
COIN COINBASE GLOBAL INC 1.7%
Value $4.552M Shares 17,169 Share Price $265.12 Est. Cost/Share $109.20 Unrealized @ Report Date +142.8%
— KRONOS BIO INC 0.6%
Value $1.687M Shares 1,297,959 Share Price $1.30 Est. Cost/Share $29.87 Unrealized @ Report Date —
NMRA NEUMORA THERAPEUTICS INC. 0.3%
Value $755K Shares 54,894 Share Price $13.75 Est. Cost/Share $16.17 Unrealized @ Report Date -15.0%
— AKILI INC 0.1%
Value $158K Shares 545,295 Share Price $0.29 Est. Cost/Share $1.12 Unrealized @ Report Date —